Indonesia, April 27 -- An estimated ~14.7% weight loss at 18 months was achieved in one of the first studies evaluating integrated GLP-1 therapies and digital coaching in a multi-ethnic Asian population (n=708). This matched gold-standard clinical trial results, with digital coaching acting as a measurable multiplier.

Singapore (ANTARA/PRNewswire)- GLP-1 medications are transforming obesity treatment, but real-world results consistently fall short of clinical trial outcomes, which sits at around 9% at 12 months, well below the 15% reported in landmark trials like STEP 1, largely due to high discontinuation rates, suboptimal dosing, and lack of structured behavioral support.

A new peer-reviewed study, published in the International Journ...